Chromosomal alterations in ductal carcinomas In situ and their In situ recurrences

Journal of the National Cancer Institute

Volumn 92, Issue 4, 2000, Pages 313-320

  Waldman, Frederic M ^a,c   DeVries, Sandy ^a   Chew, Karen L ^a   Moore II, Dan H ^a   Kerlikowske, Karla ^b   Ljung, Britt Marie ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BASE PAIRING; BREAST CARCINOMA; CANCER INVASION; CANCER RECURRENCE; CANCER SCREENING; CARCINOMA IN SITU; CHROMOSOME 17Q; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; DNA DETERMINATION; HUMAN; HUMAN TISSUE; MAMMOGRAPHY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0034673232     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.4.313     Document Type: Article

References (40)

1. Kerlikowske K, Barclay J, Grady D, Sickles EA, Ernster V. Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. J Natl Cancer Inst 1997;89:76-82.
2. Lagois MD. Heterogeneity of duct carcinoma in situ (DCIS). Relationship of grade and subtype analysis to local recurrence and risk of invasive transformation. Cancer Lett 1995;90:97-102.
3. Boyages J. Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta analysis. Cancer 1999;85:616-28.
4. Silverstein MJ, Barth A, Poller DN, Gierson ED, Colburn WJ, Waisman JR, et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 1995;31A: 1425-7.
5. Silverstein MJ, Lagois MD, Groshen S, Waisman JR, Lewinsky BS, Martino S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. New Engl J Med 1999;340:1455-61.
6. White J, Levine A, Gustafson G, Wibish K, Ingold J, Pettinga J, et al. Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1995;31:791-7.
7. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 1996; 275:913-8.
8. Fowble B, Hanlon AL, Fein DA, Hoffman JP, Sigurdson ER, Patchefsky A, et al. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ. Int J Radiat Oncol Biol Phys 1997;38: 949-57.
9. Warneke J, Grossklaus D, Davis J, Stea B, Bebb G, Taylor C, et al. Influence of local treatment on the recurrence rate of ductal carcinoma in situ. J Am Coll Surg 1995;180:683-8.
10. Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328: 1581-6.
11. Habel LA, Daling JR, Newcomb PA, Self SG, Porter PL, Stanford JL, et al. Risk of recurrence after ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 1998;7:689-96.
12. Hetelekidis S, Collins L, Silver B, Manola J, Gelman R, Cooper A, et al. Predictors of local recurrence following excision alone for ductal carcinoma in situ. Cancer 1999;85:427-31.
13. Holland PA, Gandhi A, Know WF, Wilson M, Baildam AD, Bundred NJ, The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ. Br J Cancer 1998;77:110-4.
14. Ratanawichitrasin A, Ryhicki LA, Steiger E, Grundfest-Broniatowski S, Hermann RE, Crowe JP. Predicting the likelihood of residual disease in women treated for ductal carcinoma in situ. J Am Coll Surg 1999;88:17-21.
15. Isola JJ, Kallioniemi OP, Chu LW, Fuqua SA, Hilsenbeck SG, Osborne CK, et al. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 1995; 147:905-11.
16. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-21.
17. rd, Ljung BM, Thor A, et al. Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer 1997;19:267-72.
18. nd, Waldman FM. Chromosomal alterations in ulcerative colitis-related neoplastic progression. Gastroenterology 1997;113:791-801.
19. DeVries S, Gray JW, Pinkel D, Waldman FM. Comparative genomic hybridization. In: Dracopoli NC, Haines JL, Korf BR, Moir DT, Morton CC, Seidman JG, et al., editors. Current protocols in human genetics. New York (NY): John Wiley & Sons; 1995. Unit 4.6.
20. Piper J, Rutovitz D, Sudar D, Kallioniemi A, Kallioniemi OP, Waldman FM, et al. Computer image analysis of comparative genomic hybridization. Cytometry 1995;19:10-26.
21. S-PLUS for Unix guide to statistics. Seattle (WA). Cluster analysis, chapt 20. Data Analysis Products Division, MathSoft; 1998.
22. Hahn GJ, Meeker WQ. Table A15g. In: Statistical intervals. New York (NY): John Wiley & Sons; 1991.
23. Hovey RM, Chu L, Balazs M, DeVries S, Moore D, Sauter G, et al. Genetic-alterations in primary bladder cancers and their metastases. Cancer Res 1998;58:3555-60.
24. Pollack JR, Perous CM, Alizadeh AA, Eisen MB, Pergamenschikov A, Williams CF, et al. Genome wide analysis of DNA copy number changes using cDNA microarrays. Nat Genet 1999;23:41-6.
25. Lininger RA, Fujii H, Man YG, Gabrielson E, Tavassoli FA. Comparison of loss of heterozygosity in primary and recurrent ductal carcinoma in situ of the breast. Mod Pathol 1998;11:1151-9.
26. Aldaz CM, Chen T, Sahin A, Cunningham J, Bondy M, Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas. Cancer Res 1995; 55:3976-81.
27. Fujii H, Marsh C, Cairns P, Sidranski D, Gabrielson E. Genetic divergence in the clonal evolution of breast cancer. Cancer Res 1996;56:1493-7.
28. Marsh KL, Varley JM. Loss of heterozygosity at chromosome 9p in ductal carcinoma in situ and invasive carcinoma of the breast. Br J Cancer 1998; 77:1439-47.
29. O'Connell P, Pekkel V, Fuqua S, Osbome CK, Allred DC. Molecular genetic studies of early breast cancer evolution. Breast Cancer Res Treat 1994;32:5-12.
30. O'Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM, Allred DC. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst 1998;90:697-703.
31. Radford DM, Phillips NJ, Fair KL, Ritter JH, Holt M, Donis-Keller H. Allelic loss and the progression of breast cancer. Cancer Res 1995;55: 5180-3.
32. Zhuang Z, Merino MJ, Chuaqui R, Liotta LA, Emmert-Buck MR. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Cancer Res 1995;55:467-71.
33. Fujii H, Szumel R, Marsh C, Zhou W, Gabrielson E. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast. Cancer Res 1996;56:5260-5.
34. Radford DM, Fair KL, Phillips NJ, Ritter JH, Steinbrueck T, Holt MS, et al. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. Cancer Res 1995;55:3399-405.
35. James LA, Mitchell EL, Manasce L, Varley JM. Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma. Oncogene 1997;14:1059-65.
36. Kuukasjarvi T, Tanner M, Pennanen S, Karhu R, Kallioniemi OP, Isola J. Genetic changes in intraductal breast cancer detected by comparative genomic hybridization. Am J Pathol 1997;150:1465-71.
37. Alle KM, Henshall SM, Field AS, Sutherland RL. Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clin Cancer Res 1998;4:847-54.
38. Murphy DS, Hoare SF, Going JJ, Mallon EA, George WD, Kaye SB, et al. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. J Natl Cancer Inst 1995;87:1694-704.
39. O'Malley FP, Vnencak-Jones CL, Dupont WD, Parl F, Manning S, Page DL. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data. Lab Invest 1994; 71:67-72.
40. Rosen PP, Oberman HA. Tumors of the mammary gland. Washington (DC): Armed Forces Institute of Pathology; 1992. p.157-257.